Trial intelligence / Profile preview

Slow-release methylphenidate for methamphetamine dependence

IRCT201202281556N38Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Mar 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, single-arm trial of methylphenidate in methamphetamine use disorder (MUD), sponsored by Tehran University of Medical Sciences. Started Mar 2012; status: completed.

02

Drugs

methylphenidate
03

Conditions

methamphetamine use disorder (MUD)

Beyond the preview

Go deeper on IRCT201202281556N38.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201202281556N38.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call